WallStSmart

Health In Tech, Inc. Class A Common Stock (HIT)vsSAP SE ADR (SAP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

SAP SE ADR generates 109458% more annual revenue ($37.34B vs $34.08M). SAP leads profitability with a 19.6% profit margin vs -2.4%. SAP earns a higher WallStSmart Score of 59/100 (C).

HIT

Avoid

29

out of 100

Grade: F

Growth: 7.3Profit: 2.0Value: 5.0Quality: 8.5
Piotroski: 3/9Altman Z: 4.29

SAP

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 8.5Value: 4.7Quality: 6.8
Piotroski: 6/9Altman Z: 3.11
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HIT.

SAPSignificantly Overvalued (-34.7%)

Margin of Safety

-34.7%

Fair Value

$145.83

Current Price

$184.77

$38.94 premium

UndervaluedFair: $145.83Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HIT2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.2910/10

Safe zone — low bankruptcy risk

SAP4 strengths · Avg: 9.3/10
Operating MarginProfitability
30.0%10/10

Strong operational efficiency at 30.0%

Altman Z-ScoreHealth
3.1110/10

Safe zone — low bankruptcy risk

Market CapQuality
$192.92B9/10

Large-cap with strong market position

Free Cash FlowQuality
$3.27B8/10

Generating 3.3B in free cash flow

Areas to Watch

HIT4 concerns · Avg: 2.5/10
Market CapQuality
$64.69M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-3.7%2/10

ROE of -3.7% — below average capital efficiency

Free Cash FlowQuality
$-3.68M2/10

Negative free cash flow — burning cash

SAP0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : HIT

The strongest argument for HIT centers on Debt/Equity, Altman Z-Score.

Bull Case : SAP

The strongest argument for SAP centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 19.6% and operating margin at 30.0%. PEG of 1.44 suggests the stock is reasonably priced for its growth.

Bear Case : HIT

The primary concerns for HIT are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : SAP

No major red flags identified for SAP, but monitor valuation.

Key Dynamics to Monitor

HIT profiles as a turnaround stock while SAP is a mature play — different risk/reward profiles.

HIT is growing revenue faster at 9.4% — sustainability is the question.

SAP generates stronger free cash flow (3.3B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SAP scores higher overall (59/100 vs 29/100), backed by strong 19.6% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Health In Tech, Inc. Class A Common Stock

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Health In Tech, Inc. (HIT) is a leading innovator in the digital health sector, specializing in technology solutions that enhance healthcare delivery and patient outcomes. Utilizing advanced data analytics and proprietary software, HIT enables healthcare providers and patients to make informed decisions, thereby increasing operational efficiencies. The company’s strong commitment to compliance and cybersecurity positions it favorably within the rapidly growing digital health landscape. As the market continues to evolve, HIT is strategically positioned for growth, aiming to be a pivotal player in the global advancement of technology-driven healthcare solutions.

SAP SE ADR

TECHNOLOGY · SOFTWARE - APPLICATION · USA

SAP SE is a global enterprise application software company. The company is headquartered in Walldorf, Germany.

Visit Website →

Want to dig deeper into these stocks?